Randomized placebo-controlled cross-over designs in clinical trials: A gold standard to be reassessed

Current Medical Research and Opinion

Volumn 28, Issue 2, 2012, Pages 245-248

  Leonard, Guillaume ^a   Lafrenaye, Sylvie ^a   Goffaux, Philippe ^b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Carry over effects; Clinical trials; Cross over designs; Placebo; Treatment efficacy

Indexed keywords

PLACEBO;

ARTICLE; CLINICAL RESEARCH; CROSSOVER PROCEDURE; DRUG RESEARCH; GOLD STANDARD; HUMAN; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHAM PROCEDURE;

BIAS (EPIDEMIOLOGY); CROSS-OVER STUDIES; HUMANS; PLACEBO EFFECT; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84856501227     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.653558     Document Type: Article

References (13)

1. Andre-Obadia N, Mertens P, Gueguen A, et al. Pain relief by rTMS: differential effect of current flow but no specific action on pain subtypes. Neurology 2008;71:833-40
2. Andre-Obadia N, Magnin M, Garcia-Larrea L. On the importance of placebo timing in rTMS studies for pain relief. Pain 2011;152:1233-7
3. Goffaux P, Leonard G, Marchand S, et al. Placebo analgesia. In: Beaulieu P, Lussier D, Porreca F, Dickenson AH, eds. Pharmacology of Pain. Seattle: IASP Press, 2010: pp. 451-73
4. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003;23:4315-23 (Pubitemid 36958452)
5. Berthelot JM, Le Goff B, Maugars Y. The hawthorne effect: stronger than the placebo effect? Joint Bone Spine 2011;78:335-6
6. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term) evidence for a "trial effect". J Clin Epidemiol 2001;54:217-24 (Pubitemid 32162034)
7. Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci 2005;6:545-52 (Pubitemid 40942821)
8. Leonard G, Goffaux P, Marchand S. Deciphering the role of endogenous opioids in high-frequency TENS using low and high doses of naloxone. Pain 2010;151:215-19
9. Putt ME, Ravina B. Randomized, placebo-controlled, parallel group versus crossover study designs for the study of dementia in Parkinson's disease. Control Clin Trials 2002;23:111-26 (Pubitemid 34273845)
10. Senn S. Cross-over Trials in Clinical Research. New York: John Wiley & Sons, 2002
11. Fedele L, Marchini M, Acaia B, et al. Dynamics and significance of placebo response in primary dysmenorrhea. Pain 1989;36:43-7 (Pubitemid 19024965)
12. Chizh BA, Priestley T, Rowbotham M, et al. Predicting therapeutic efficacy-experimental pain in human subjects. Brain Res Rev 2009;60:243-54
13. Colloca L, Lopiano L, Lanotte M, et al. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 2004;3:679-84 (Pubitemid 39370638)